There is no specific A1C number required to get an Ozempic prescription. The FDA approves Ozempic for any adult with type 2 diabetes, regardless of their A1C level. However, your insurance company likely has its own A1C threshold for covering the medication, and that’s where the real barrier sits for most people.
What the FDA Actually Requires
Ozempic (semaglutide) is FDA-approved as an add-on to diet and exercise for adults with type 2 diabetes. The prescribing information contains no minimum or maximum A1C requirement. A doctor can legally prescribe it to anyone with a type 2 diabetes diagnosis, whether their A1C is 6.5% or 12%.
Ozempic also carries two additional approved uses: reducing the risk of major cardiovascular events (heart attack, stroke, cardiovascular death) in adults with type 2 diabetes and established heart disease, and protecting kidney function in adults with type 2 diabetes and chronic kidney disease. Neither of these indications specifies an A1C cutoff either.
The A1C Thresholds Insurance Companies Use
While your doctor can prescribe Ozempic at any A1C level, your insurer will almost certainly require prior authorization before agreeing to pay for it. This is where specific A1C numbers come into play, and the requirements vary by plan.
A representative example comes from Aetna’s coverage policy. Under their criteria, Ozempic is covered for patients with type 2 diabetes who meet one of several conditions:
- A1C of 7.5% or greater when the patient needs combination therapy (meaning a second medication alongside something like metformin)
- Any A1C level if the patient has tried metformin and it didn’t work, caused intolerable side effects, or is medically contraindicated
- Any A1C level if the patient has established cardiovascular disease
Most major insurers follow a similar pattern. They want to see that you’ve tried metformin first (called “step therapy”) or that your blood sugar remains poorly controlled despite other treatments. The 7.5% threshold is common across many plans, but some set it higher or lower. Your specific plan documents or a call to your insurance company will give you the exact number you need.
If you’re already on a GLP-1 medication (the drug class Ozempic belongs to) and switching to Ozempic, insurers typically want evidence that your A1C has dropped since starting that therapy rather than requiring a specific number.
What A1C Means for Your Diagnosis
Since Ozempic requires a type 2 diabetes diagnosis, understanding where you fall on the A1C scale matters. The American Diabetes Association defines three ranges:
- Normal: below 5.7%
- Prediabetes: 5.7% to 6.4%
- Diabetes: 6.5% or higher
If your A1C is in the prediabetes range, you don’t qualify for Ozempic under its FDA-approved indication for type 2 diabetes. Some doctors prescribe it off-label for weight management, but insurance coverage for off-label use is rare and usually denied.
How Much Ozempic Lowers A1C
Clinical trials across the SUSTAIN program show that Ozempic meaningfully reduces A1C in people with type 2 diabetes. The lower dose (0.5 mg weekly) reduced A1C by roughly 0.3 to 0.8 percentage points more than comparison treatments, while the higher dose (1.0 mg weekly) reduced it by about 0.4 to 1.1 percentage points more. For someone starting at an A1C of 8.5%, that could mean dropping into the low 7s or even high 6s, depending on the dose and what other medications they’re taking.
These reductions matter for insurance renewals too. Many plans require proof that your A1C has improved since starting the medication before they’ll authorize refills. If your A1C doesn’t budge, your insurer may stop covering it.
Getting the Prescription in Practice
Your doctor will typically order bloodwork before writing the prescription, including a fasting blood glucose test and an A1C measurement. A1C reflects your average blood sugar over the previous two to three months, so a single good or bad day won’t skew the result.
If your A1C meets your insurer’s threshold and you have a confirmed type 2 diabetes diagnosis, your doctor’s office will submit a prior authorization request. This usually includes your A1C result, a list of diabetes medications you’ve already tried, and documentation of your diagnosis. Approval can take anywhere from a few days to a few weeks.
If your A1C falls below your insurer’s cutoff, you still have options. Your doctor can appeal the decision with clinical justification, or you may qualify through one of the alternate pathways (like a history of metformin intolerance or existing cardiovascular disease). Some patients pay out of pocket, though Ozempic’s list price without insurance runs close to $1,000 per month. Novo Nordisk offers a savings card that can reduce costs for commercially insured patients, but the discount varies by plan.